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Abstract : Periodontal disease results in destruction of periodontal tissues(cementum, alveolar bone and periodontal
ligament) which may ultimately lead to tooth loss. To date, there is no ideal treatment approach in achieving optimal
periodontal tissue regeneration. Recruitment of progenitor cells to the site which could differentiate into cemento-
blasts, osteoblasts and periodontal ligament-forming cells are needed and recently, using pluripotent stem cells iso-
lated from various tissues in conjugation with growth and differentiation factors have been presented to lead
periodontal tissue regeneration. This study evaluated the effect of E coli expressed recombinant human bone mor-
phogenetic protein-2(ErhBMP-2) to periodontal ligament stem cells(PDLSCs) and bone marrow stem
cells(BMSCs) on periodontal tissue regeneration. rhBMP-2 those expressed from E coli was treated on ex-vivo
expanded human BMSCs and PDLSCs to evaluate its regenerative effect in vivo and in vitro. Cementum, PDL-like
tissues and bone were regenerated in transplanting PDLSCs and BMSCs, respectively. There was enhanced tissue
regeneration when ErhBMP-2 was treated to PDLSCs, but not with BMSCs. Similar results were observed with in
vitro experiments. Though further studies are needed, the results suggest a possible treatment approach in combining
ErhBMP-2 and PDLSCs for periodontal tissues regeneration.
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 1. Introduction
Periodontal tissues are complex, composed of cementum,
alveolar bone and periodontal ligament. Once periodontitis is
established, destruction of these tissues occurs and regeneration
of these tissues becomes one of the major goal in periodontal
treatment. Efforts in regenerating damaged periodontal tissues
has been carried out, such as root surface conditioning1,
implantation of bone graft material2,3and guided tissue
regeneration(GTR).4,5 However, treatment outcome of such
approaches were often unpredictable, showing repair healing
pattern and mostly dependent on regenerative potential of
existing periodontal defect morphology.6,7 Recently, applying
biological growth and differentiation factors with or without a
biocompatible scaffold to defects has been a new approach in
regenerating periodontal tissues.8-10 
Bone morphogenetic proteins(BMPs) are members of the
transforming growth factor-β super-family which has the
ability to induce bone.11 When BMP is implanted on bone
defects, new bone is effectively formed and when implanted on
ectopic sites, ectopic bone formation is induced.12 In 1988
Wozney11 developed in recombining human BMP(rhBMP),
and from then many clinical studies were carried out,
introducing numerous products until today.13-18 Most of the
rhBMPs used today have been obtained from Chinese hamster
ovary(CHO) cells.19 However, unfortunately rhBMPs obtained
from mammalian CHO cells are cost effective and therefore
may not be easily applied clinically. In order to be a viable
commercial product, BMPs recombined from low level
animals such as E coli could be used. And several trials have
presented its production and evaluation as an alternative to
rhBMPs produced by mammalian cells.20-23
Periodontal ligament tissues are reported to have several cell
types, including mesenchymal stem cells which serve as a
source of renewing progenitor cells of cementoblasts,
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osteoblast and fibroblast.24,25 Several studies presented
periodontal tissue regeneration in transplanting periodontal
ligament derived stem cells (PDLSCs) in periodontal defects of
animals26-29 and Seo et al28 successfully isolated stem cells from
human periodontal ligament, introducing a new approach to
periodontal regeneration via tissue engineering. The stem cells
isolated from periodontal ligament showed common
characteristics to other stem cells. It formed mineralization
deposits of alizarin red positive nodules in vitro and cementum/
periodontal ligament structure formation following
implantation in vivo, suggesting a potential use of stem cell-
based therapies to damaged periodontal tissues.
In the present study, E coli expressed rhBMP-2(ErhBMP-2)
was treated to periodontal ligament stem cells(PDLSCs) and
bone marrow stem cells(BMSCs) to evaluate its effect on
periodontal tissue regeneration. 
2. Material and Methods
2.1 In Vivo Transplantation
In order to evaluate the effect of ErhBMP-2, in vivo
transplantation model using nude mouse was carried out with
human PDLSC for cementum, periodontal ligament, and
BMSCs for bone regeneration.
 
2.1.1 Stem Cell Isolation and Culture
Bone marrow stem cells(BMSCs) were obtained from a
commercially available resource(AllCells LLC, Berkeley, CA,
USA). Periodontal stem cell isolation was followed as the
previously published paper.28 Briefly, teeth extracted for
orthodontic treatment were used and an informed consent was
received by all patients undergoing teeth extraction.
Periodontal ligament tissues were separated from the root
surface by use of a scapel and were minced into smallest size as
possible. Periodontal ligament membrane was digested three
times for 1h in a solution of 3 mg/mL collagenase type
I(WAKO, Tokyo, Japan) and 4 mg/mL dipase(GIBCO BRL,
Grand Island, NY, USA) at 37oC. Single cell suspensions were
obtained by passing through 70 µm pore size strainer(Falcon,
BD Labware, Franklin Lakes, NJ, USA) and the cells(1×104)
were seeded on to 10 cm culture dishes containing alpha-
modification of Eagle's medium(α-MEM, GIBCO BRL)
supplemented with 15% fetal bovine serum(GIBCO BRL), 100
µmol/L ascorbic acid 2-phosphate(Sigma-Aldrich, St Louis,
MO, USA), 2 mmol/L glutamine, 100 U/mL penicillin, and 100
ug/mL streptomycin(GIBCO BRL) and incubated at 37oC in
5% carbon dioxide. Single cell colony was observed after 7
days and P0 passage of periodontal ligament stem cells was
cultured. The P3 passage cells were used for the study and the
cells were treated with 100 ng/mL of ErhBMP-2 for 3 days
after reaching sub-confluence.
 
2.1.2 Transplantation
A total of fifteen nude mice with 3 in each group was used.
Animal selection, management, and surgical procedures
followed a protocol approved by the Animal Care and Use
Committee, Yonsei Medical Center, Seoul, Korea.
Par t icula ted macroporous b iphasic  calc ium
phosphate(MBCP™, Biomatlante Sarl, France) bone graft
material was used as a carrier. 80 mg of MBCP was mixed with
4×106 human PDLSCs(P3) or MBSCs(P3) and was
transplanted on to subcutaneous pocket of nude mouse. The
animals received one of the four experimental conditions:
MBCPonly(control), human periodontal ligament stem cells
only(PDLSC/MBCP) or bone marrow stem cells only(BMSC/
MBCP) and ErhBMP-2 treated human periodontal ligament
stem cells(ErhBMP-2/PDLSC/MBCP) or bone marrow stem
cells(ErhBMP-2/BMSC/MBCP).
The surgical procedure was performed under general
anesthesia by an intramuscular injection of Ketamine
hydrochloride(Ketalar, Yuhan Co., Seoul, Korea). The surgical
site was disinfected with iodine and a vertical incision was
made on the skin of the mouse back. After flap reflection, a
subcutaneous pocket was prepared by a blunt dissection and
respective treated materials according to the experimental
design were implanted. The animals were healed for 8 weeks
and were sacrificed to obtain block sections for histological
analysis.
2.1.3 Histological Analysis
Block sections were fixed in 10% formalin. The specimens
were demineralized in 5% nitric acid, dehydrated in ethanol and
embedded in paraffin. The central sections were reduced to a
thickness of 7 µm and were stained in hematoxylin and eosin.
The histological analysis were performed using a light
microscope(Olympus BX50, Olympus Optical Co, Tokyo,
Japan).
 
2.2 In Vitro Differentiation
2.2.1 Osteogenic and Adipogenic Differentiation. 
The osteogenic and adipogenic differentiation of human
PDLSCs and BMSCs with ErhBMP-2 treatment were
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evaluated. PDLSCs were isolated following the procedure
previously described. After obtaining single-cell suspensions,
the cells were seeded into 24 well culture dish with 1×104 cells
on each well, and stem cells of P0 passage was able to be
cultured. The cells were cultured until it reached an over
confluent stage(P3) and 100 ng/mL of ErhBMP-2 were treated
for 3 days. The culture medium was changed within 2~3 days
of interval containing equal concentration of ErhBMP-2. The
culture medium used for osteogenic induction was composed
of α-MEM with 15% FBS (GIBCO BRL), 2 mML-glutamine,
100 mM L-ascorbic acid 2-phosphate, 1.8 mM KH2PO4, 10 nM
dexamethasone(Sigma-Aldrich), 100 U/mL penicillin and 100
mg/mL streptomycin(GIBCO BRC). For adipogenic induction,
the culture medium was composed of α-MEM with 15% FBS,
2 mM L-glutamine, 100 mM L-ascorbic acid 2-phosphate, 0.5
mM isobutyl-methylxanthine, 60 mM indomethacin, 0.5 mM
hydrocortisone, 10mM insulin, 100 U/mL penicillin and 100
mg/mL streptomycin. After 2(adipogenic differentiation) and 4
weeks(osteogenic differentiation) of induction the cells were
stained with oil red and alizarin red stain for evaluation. 
2.2.2 Western Blotting
Runx-2, Osteocalcin, beta-Actin antibodies(Santa Cruz
Biotechnology, SantaCruz, CA, USA) at dilutions ranging from
1:200 to 1:1000 were used for western blot. Western blot
analyses were carried out as previously reported.30
3. Results
 
3.1 In Vivo Transplantation
In MBCP only implanted control group, the MBCP material
particles were surrounded with loose connective tissues
associated with multi-cellular giant cells. There were no
findings of periodontal tissue regeneration(Fig 1). In hPDLSC
only implanted group, a thin layer of cementum like tissues
lined on the surface of MBCP particles(Fig 2). And along this
Figure 1. Histological section of control group(MBCP only). The
MBCP was surrounded with loose connective tissue(H-E stain,
original magnification ×100).
Figure 2. Histological section of PDLSCs implanted group. Regeneration of cementum and periodontal ligament like tissues were
observed around MBCP(left). Higher magnification shows collagen fiber embedment(right)(H-E stain, original magnification; left ×100,
right ×400).
Figure 3. Histological section of ErhBMP-2 treated PDLSCs implanted group. Note thicker cementum formation and dense periodontal
ligament like tissues around MBCP(H&E stain, original magnification; left ×100, right ×400).
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cementum like tissues, dense collagen fibers with sparse cells
were observed which resembled periodontal ligament tissues.
These fibers resembled Sharpey’s fiber, integrating and
embedding with newly formed cementum like tissues(Fig 3).
The alignment of periodontal ligament like fibers did not show
any difference between groups presenting the fibers(Figs 2 and
3). In ErhBMP-2 treated PDLSCs implanted group newly
formed cementum like tissues and periodontal ligament like
tissues were presented along the surface of MBCP particles
with thickest layer of cementum like tissue and more
cementoblastic cells in ErhBMP-2 treated PDLSCs group than
the untreated(Figs 2 and 3).
In BMSCs only implanted group, a layer of bone was
observed around the MBCP particles. The newly formed bone
had osteocytes and was in lamellar form(Fig 4). Finding of
bone marrow was also observed representing typical form of
the bone structure. In ErhBMP-2 treated group, newly formed
bone was also present. However, the amount of bone tissue
formation seemed to be less than the untreated group(Fig 5). 
3.2 In Vitro Differentiation
Alizarin red-positive nodules were observed on the culture
dishes. The area of nodules formed per surface area was
significantly greater when treated with ErhBMP-2 than
untreated BMSCs(Fig 6). 
In adipogenic differentiation test, oil red O-positive
adipocytes were formed and were significant with ErhBMP-2
treated BMSCs(Fig 7). However, there was no finding of oil red
O-positive adipocytes formed with PDLSCs whether treated
with ErhBMP-2 or not(Fig 8). 
Western blot analysis showed otseoblastic markers(Runx-2,
Osteocalcin, Beta-Actin) expression in both ErhBMP-2 treated
and untreated BMSCs with less significant expression with
treated BMSCs(Fig 9). 
4. Discussion
Regeneration of periodontal tissues destroyed by
periodontitis is the main goal in periodontal treatment.
Regenerating periodontal tissues is challenging and many
mechanical, chemical and surgery approaches have been
performed to regenerate the tissues(PDL, cementum and
bone).1-5 However, the results of the conventional periodontal
treatment were greatly dependent on defect morphology and
residual vital periodontal cells, and sites with periodontitis are
mostly deprived of vital periodontal cells.6 
Cells in periodontal ligaments have multiple cell types which
Figure 4. Histological section of BMSCs implanted group. Regener-
ation of bone structures were observed around MBCP(H&E stain,
original magnification ×100).
Figure 5. Histological section of ErhBMP-2 treated BMSCs
implanted group. The amount of bone regeneration was not sig-
nificantly increased after ErhBMP-2 treatment(H&E stain, origi-
nal magnification ×100).
Figure 6. Results of alizarin red stain of rhBMP-2 untreated(left) and treated(right) BMSCs.
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contain progenitor cells in regenerating periodontal tissues, and
studies have presented PDL cells to have osteoblastic and
cementoblastic properties.24,25,28 Seo et al,28 presented that
human periodontal ligament cells contain multipotent stem
cells, regenerating cementum and periodontal ligament like
tissues when transplanted into immunocompromised mice.
However, unlike with other stem cells, periodontal ligament
stem cells seem to present minimum bone forming property.27,28
BMPs induce bone formation, and many in vivo and in vitro
studies with rhBMPs have shown ectopic bone and cartilage
formation and osteoblastic makers expression11-15,17,18 rhBMPs
are usually recombined by using mammalian CHO cells.19
However, its high cost makes it difficult in clinical application
and therefore, BMPs recombined by using E coli has been
evaluated as an alternative.20,22,23
The objective of the present study was to evaluate the effect
of E coli expressed rhBMP-2(ErhBMP-2) in tissue
regeneration of BMSCs and PDLSCs. ErhBMP-2 was treated
on ex-vivo expanded human BMSCs and PDLSCs to evaluate
its regenerative effect in vivo and in vitro.
BMSCs and PDLSCs were mixed with MBCP bone material
and were transplanted on subcutaneous skin of nude mouse.
Histological findings after 8 weeks showed newly formed bone
on the surface of MBCP particles with BMSCs and cementum
and periodontal ligament like tissue formation with PDLSCs.
In newly formed periodontal ligament like tissues, sparse fibers
were observed, embedding to the newly formed cementum like
tissue which resembled sharpey’s fiber attachment of normal
periodontal ligament(Fig 2). These results were consistent with
other studies of PDLSCs and BMSCs.27,28,31,32 Seo et al,28
evaluated ex-vivo expanded PDLSCs, BMSCs and dental pulp
stem cells(DPSCs) transplanted on to immunocompromised
mouse. The histological findings presented cementum and PDL
like tissues with PDLSCs, bone and marrow structures with
BMSCs and dentin and pulp like tissue formation with DPSCs.
When ErhBMP-2 was treated to the stem cells, there was an
enhancement in cementum and denser PDL like tissue
Figure 7. Oil red stain of ErhBMP-2 untreated(left) and treated(right) BMSCs.
Figure 8. Oil red stain of ErhBMP-2 untreated(left) and treated(right) PDLSCs.
Figure 9. Western blot analysis of BMSCs.
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formation with PDLSCs. The layer of the newly formed
cementum was thick with more cells. However, with BMSCs,
the newly formed bone seemed to be less than untreated
ErhBMP-2 cells instead of enhancement. These findings were
also confirmed with the results of in vitro experiments. Alizarin
red positive nodules and oil red O-positive lipid cells were more
significant with untreated BMSCs cells in both osteogenic and
adipogenic differentiation analysis. Results of the western blot
also showed less significant expression of osteoblastic markers
with ErhBMP-2 treated groups than untreated controls. These
results show contrary with other studies of rhBMP and stem
cells. Kim et al33 presented synergistic bone formation with
rhBMP-2 and human mesenchymal cells(MSC) in histological
and immunochemical analysis. Friedman et al34 also reported
an upregulation of osteoblast-related gene expression when
rhBMP-6 was treated to human MSCs.
The present study hypothesized the stem cells to show
enhanced tissue regeneration when treated with ErhBMP-2.
However, the enhanced effect was only observed with PDLSCs
and not with BMSCs. The reason for such results could be
assumed to be due to the use of E coli expressed rhBMP-2.
rhBMP-2 expressed by prokaryotic cells such as E coli is
presented to produce less bone induction than eukaryotic CHO
cell expressed rhBMP-2.35 However, contrary results are also
reported, concluding that bone inductive effect of Ecoli derived
rhBMP-2 was similar to that of CHO cell derived rhBMP-
2.20,36,37 Since controversy still exist on the bone inductive
effect of E coli expressed rhBMP-2, further evaluation is
needed. Another reason in explaining reduced bone inductive
effect with ErhBMP-2 treatment could be due to treatment time
and dose of ErhBMP-2. In the present study, ex-vivo expanded
cells were treated with 100 ng/mL of ErhBMP-2 for 3 days
before transplantation. Short treatment time and low dose of
ErhBMP-2 may have not allowed the cells to induce bone
actively. Though dose dependency is affected by several factors
such as carrier system, species, experimental site and
observation period38, controversial results are only currently
present therefore, effect of dose of rhBMP-2 can also be a factor
in producing such results. 
In conclusion, within the limits of the present study, when E
coli expressed rhBMP-2 was treated on to human PDLSCs and
BMSCs, there was enhanced cementum and PDL-like tissue
formation in PDLSCs but no significance in BMSCs. Though
further studies are needed in relation to ErhBMP-2 and stem
cells, the results suggest a possibility in combine use of
ErhBMP-2 and PDLSCs for periodontal tissues regeneration.
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